Loading…
Loading…
HSAQ (Health Sciences Acquisitions Corporation 2) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
HSAQ does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for HSAQ and 80,000+ other tickers.
See exactly how HSAQ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HSAQ and 80,000+ other tickers.
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North America or Europe. The company was established in 2020 and is headquartered in New York, New York.
Institutional and Insider Ownership 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 87.8% of Defiance Daily Target 2X Long LMND ETF shares are held by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are held by company insiders. Comparatively, 6.6% of Defiance Daily Target 2X Long LMND
Health Sciences Acquisitions Co. 2 (NASDAQ: HSAQ - Get Free Report)'s stock price rose 1.3% on Wednesday. The company traded as high as $4.72 and last traded at $4.61. Approximately 244,723 shares were traded during mid-day trading, an increase of 19% from the average daily volume of 205,918 shares. The stock had previously closed at
Shares of Health Sciences Acquisitions Co. 2 (NASDAQ: HSAQ - Get Free Report) dropped 2.9% during mid-day trading on Tuesday. The company traded as low as $4.4750 and last traded at $4.66. Approximately 374,411 shares were traded during trading, an increase of 82% from the average daily volume of 205,918 shares. The stock had previously
INVO Fertility (NASDAQ: IVF - Get Free Report) and Health Sciences Acquisitions Co. 2 (NASDAQ: HSAQ - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Analyst Recommendations This is